SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership[Amend]
SEC Accession No. 0001193125-14-402302
Filing Date
2014-11-07
Accepted
2014-11-07 08:57:29
Documents
4
Filing Date Changed
2014-11-07
Group Members
PS MANAGEMENT GP, LLCWILLIAM A. ACKMAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 13 TO SCHEDULE 13D d816490dsc13da.htm SC 13D/A 85214
2 EX-99.39 d816490dex9939.htm EX-99.39 7509
3 GRAPHIC g816490p1.jpg GRAPHIC 15868
4 GRAPHIC g816490p2.jpg GRAPHIC 9715
  Complete submission text file 0001193125-14-402302.txt   129798
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40724 | Film No.: 141202806
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A